Editorials |
From the Division of Biomedical Sciences (Cell and Molecular Biology Section) (A.C.) and the National Heart and Lung Institute Division (Cardiac Medicine Section) (P.H.S.), Faculty of Medicine, Imperial College of Science, Technology and Medicine, London, UK.
Correspondence to Angela Clerk, PhD, Division of Biomedical Sciences (Cell and Molecular Biology Section), Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK. E-mail a.clerk@ic.ac.uk
See related article, pages 882890
Key Words: cardiac myocytes protein kinase C mitogen-activated protein kinases hypertrophy apoptosis
The understanding of intracellular signaling pathways and their physiological effects has been confounded by the existence of numerous isoforms of the various signaling components. Thus, many families of protein kinases comprise several subfamilies, each of which may contain multiple isoforms deriving from distinct genetic loci. Furthermore, each locus may produce multiple products through alternative splicing. A rational argument maintains that each isoform has a distinct role in cellular regulation, but evidence of this is sparse. The alternative explanation, that there is redundancy, has led to the generation of web-like diagrams of interconnecting signaling pathways as investigators attempt to decipher the wiring patterns of the cell. In the heart, two superfamilies of protein kinases, the protein kinase Cs (PKCs) and the mitogen-activated protein kinases (MAPKs), are particularly implicated in the development of cardiac pathologies.1 Both superfamilies contain numerous isoforms, but little is known about the roles of individual isoforms. In this issue of Circulation Research, Heidkamp et al2 provide some of the first data showing that specific PKC isoforms couple to distinct MAPK pathways to regulate cardiac myocyte function.
PKC and the MAPKs
The PKC superfamily comprises the "classical" cPKCs (
, ß1, ß2,
), "novel" nPKCs (
,
,
,
), "atypical" aPKCs (
,
/
), and PKC-related kinases (PRKs).3 In cardiac myocytes, cPKC
, nPKC
, nPKC
, aPKC
, and aPKC
/
are readily detectable, although cPKCß isoforms may also be significant.4 Hypertrophic agonists such as endothelin-1 (ET-1) or the
-adrenergic agonist phenylephrine (PE) activate nPKC
and nPKC
in cardiac
This article has been cited by other articles:
![]() |
E. Hochhauser, D. Leshem, O. Kaminski, Y. Cheporko, B. A. Vidne, and A. Shainberg The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 363 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. H. Mountain, M. Singh, B. Menon, and K. Singh Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKC{alpha}/beta1 and MAPKs Am J Physiol Cell Physiol, February 1, 2007; 292(2): C867 - C875. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reither, M. Schaefer, and P. Lipp PKC{alpha}: a versatile key for decoding the cellular calcium toolkit J. Cell Biol., August 14, 2006; 174(4): 521 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoshijima Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1313 - H1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. House, K. Branch, G. Newman, T. Doetschman, and J. E. J. Schultz Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2167 - H2175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malhotra, R. Begley, B. P. S. Kang, I. Rana, J. Liu, G. Yang, D. Mochly-Rosen, and L. G. Meggs PKC-{varepsilon}-dependent survival signals in diabetic hearts Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1343 - H1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, L. Zhang, and L. D. Longo PKC-induced ERK1/2 interactions and downstream effectors in ovine cerebral arteries Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R164 - R171. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Klein, A. Schaefer, D. Hilfiker-Kleiner, D. Oppermann, P. Shukla, A. Quint, E. Podewski, A. Hilfiker, F. Schroder, M. Leitges, et al. Increased Collagen Deposition and Diastolic Dysfunction but Preserved Myocardial Hypertrophy After Pressure Overload in Mice Lacking PKC{epsilon} Circ. Res., April 15, 2005; 96(7): 748 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tourkina, P. Gooz, J. Pannu, M. Bonner, D. Scholz, S. Hacker, R. M. Silver, M. Trojanowska, and S. Hoffman Opposing Effects of Protein Kinase C{alpha} and Protein Kinase C{epsilon} on Collagen Expression by Human Lung Fibroblasts Are Mediated via MEK/ERK and Caveolin-1 Signaling J. Biol. Chem., April 8, 2005; 280(14): 13879 - 13887. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Korzick, J. C. Hunter, M. K. McDowell, M. D. Delp, M. M. Tickerhoof, and L. D. Carson Chronic Exercise Improves Myocardial Inotropic Reserve Capacity Through {alpha}1-Adrenergic and Protein Kinase C-Dependent Effects in Senescent Rats J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2004; 59(11): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, M. Singh, and K. Singh Differential Regulation of Matrix Metalloproteinase-2 and -9 Expression and Activity in Adult Rat Cardiac Fibroblasts in Response to Interleukin-1{beta} J. Biol. Chem., September 17, 2004; 279(38): 39513 - 39519. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hilfiker-Kleiner, K. Kaminski, A. Kaminska, M. Fuchs, G. Klein, E. Podewski, K. Grote, I. Kiian, K. C. Wollert, A. Hilfiker, et al. Regulation of Proangiogenic Factor CCN1 in Cardiac Muscle: Impact of Ischemia, Pressure Overload, and Neurohumoral Activation Circulation, May 11, 2004; 109(18): 2227 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Metzger and M. V. Westfall Covalent and Noncovalent Modification of Thin Filament Action: The Essential Role of Troponin in Cardiac Muscle Regulation Circ. Res., February 6, 2004; 94(2): 146 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ping A new chapter in cardiac PKC signaling studies: searching for isoform-specific molecular targets. Focus on: "Isoenzyme-selective regulation of SERCA2 gene expression by protein kinase C in neonatal rat ventricular myocytes" Am J Physiol Cell Physiol, July 1, 2003; 285(1): C19 - C21. [Full Text] [PDF] |
||||
![]() |
U. Ikeda, Y. Maeda, K. Yamamoto, and K. Shimada C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes Cardiovasc Res, October 1, 2002; 56(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garcia-Dorado, M. Ruiz-Meana, F. Padilla, A. Rodriguez-Sinovas, and M. Mirabet Gap junction-mediated intercellular communication in ischemic preconditioning Cardiovasc Res, August 15, 2002; 55(3): 456 - 465. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |